Redmile Group, LLC Ac Immune Sa Transaction History
Redmile Group, LLC
- $2.54 Billion
- Q1 2024
A detailed history of Redmile Group, LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Redmile Group, LLC holds 2,007,031 shares of ACIU stock, worth $8.01 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
2,007,031
Previous 2,000,000
0.35%
Holding current value
$8.01 Million
Previous $10 Million
40.6%
% of portfolio
0.23%
Previous 0.4%
Shares
2 transactions
Others Institutions Holding ACIU
# of Institutions
41Shares Held
29MCall Options Held
92.9KPut Options Held
46.3K-
Bvf Inc San Francisco, CA14.6MShares$58.1 Million1.29% of portfolio
-
Avidity Partners Management LP Dallas, TX4.47MShares$17.8 Million0.51% of portfolio
-
Black Rock Inc. New York, NY2.54MShares$10.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.38MShares$5.52 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA1.12MShares$4.47 Million0.0% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $333M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...